2017-04-21 13:23:04 UTC

Open for Public Comment: New Therapeutic Monitoring in IBD Guideline

April 27, 2017

Review and submit your feedback on the draft AGA guideline by May 22.

The AGA Institute is seeking public comments on the technical review, clinical practice guideline and clinical decision support tool for the therapeutic monitoring of IBD. 

The technical review is an objective report of the clinical evidence underlying the recommendations for clinical practice presented in the guideline. Please review the following documents:

Submit your comments by completing this survey. The public comment period will end at noon ET on Monday, May 22.

Please note that the survey utilizes the SurveyMonkey online platform, which is best supported by the following browsers:

  • Chrome 16 and later
  • Firefox 13.0 and later
  • Safari 5.0 and later
  • Internet Explorer 9.0 and later

For the best experience, we recommend downloading the newest version of your preferred browser.

About the public comment period
This AGA evidence-based clinical practice guideline employs the GRADE system (Grades of Recommendation Assessment, Development and Evaluation), which provides a user-friendly way to rate the quality of the evidence, as well as the strength of clinical recommendations. The public comment period is an integral part of AGA’s guideline development process. Public comment allows AGA members, as well as key stakeholders, to review and comment on upcoming guidelines and their accompanying technical reviews.

Once an AGA guideline panel releases the drafts for public comment, identified stakeholders are alerted and have 30 days to submit their comments through an online survey. After the 30-day period ends, the guideline panel reviews and responds to the comments within two weeks. Revisions to the draft documents are at the discretion of the panel, but all comments must be considered and responses internally documented.

Learn more about AGA's clinical practice guidelines.

More on Crohn's Disease

Crohn's & Colitis Congress™ (A Partnership of the Crohn's & Colitis Foundation and American Gastroenterological Association)

Jan. 18, 2018

Expand your knowledge, network with IBD leaders, spark innovative research and get inspired to improve patient care.

Putting Patients First: Digital Health Tools to Empower IBD Patients

Jan. 18, 2018

Discover how advances in digital health can help you monitor and support IBD patients remotely and dynamically, improve face-to-face care, and drive clinical decisions through shared decision-making.

Get Your Questions Answered on Biosimilar Therapies

Dec. 7, 2017

Join inflammatory bowel disease (IBD) experts on Dec. 11, 2017, 8-8:45 p.m. ET, for a free webinar on biosimilar therapies.